Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Current Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Current Assets for 16 consecutive years, with $78.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 9.69% to $78.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $78.3 million, a 9.69% increase, with the full-year FY2024 number at $67.1 million, up 3.46% from a year prior.
  • Current Assets was $78.3 million for Q3 2025 at Xtant Medical Holdings, up from $75.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $78.3 million in Q3 2025 to a low of $36.6 million in Q1 2023.
  • A 5-year average of $56.3 million and a median of $49.4 million in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: fell 14.44% in 2023, then surged 81.87% in 2024.
  • Xtant Medical Holdings' Current Assets stood at $44.3 million in 2021, then increased by 11.25% to $49.3 million in 2022, then skyrocketed by 31.53% to $64.9 million in 2023, then grew by 3.46% to $67.1 million in 2024, then increased by 16.71% to $78.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Current Assets are $78.3 million (Q3 2025), $75.6 million (Q2 2025), and $69.1 million (Q1 2025).